Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.

Planutis AK, Holcombe RF, Planoutene MV, Planoutis KS.

Anticancer Drugs. 2015 Jul 20. [Epub ahead of print]

PMID:
26196680
2.

Standardized cancer incidence disparities in Upper Manhattan New York City neighborhoods: the role of race/ethnicity, socioeconomic status, and known risk factors.

Hashim D, Farhat Z, Wallenstein S, Manczuk M, Holcombe RF, Thorpe L, Schymura MJ, Lucchini RG, Boffetta P.

Eur J Cancer Prev. 2015 Jul 16. [Epub ahead of print]

PMID:
26186470
3.
4.

Inpatient Hematology-Oncology Rotation Is Associated With a Decreased Interest in Pursuing an Oncology Career Among Internal Medicine Residents.

McFarland DC, Holland J, Holcombe RF.

J Oncol Pract. 2015 Jul;11(4):289-95. doi: 10.1200/JOP.2015.003798. Epub 2015 Jun 9.

PMID:
26060222
5.

Demographic factors and hospital size predict patient satisfaction variance-implications for hospital value-based purchasing.

McFarland DC, Ornstein KA, Holcombe RF.

J Hosp Med. 2015 Aug;10(8):503-9. doi: 10.1002/jhm.2371. Epub 2015 May 4.

PMID:
25940305
6.

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S.

Semin Cancer Biol. 2015 Apr 17. pii: S1044-579X(15)00014-0. doi: 10.1016/j.semcancer.2015.02.006. [Epub ahead of print] Review.

7.

Developing clinical research incentives for academic oncologists.

Holcombe RF, Hollinger K.

J Med Pract Manage. 2014 Nov-Dec;30(3):211-4.

PMID:
25807628
8.

AM last page. Improving health care quality: a polarity management perspective.

Holcombe RF.

Acad Med. 2015 Feb;90(2):259. doi: 10.1097/ACM.0000000000000595. No abstract available.

PMID:
25494402
9.

Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.

Galsky MD, Posner M, Holcombe RF, Lee KM, Misiukiewicz K, Tsao CK, Godbold J, Soto R, Gimpel-Tetra K, Lowe N, Oh WK.

Cancer Chemother Pharmacol. 2014 Sep;74(3):465-71. doi: 10.1007/s00280-014-2518-5. Epub 2014 Jul 15.

PMID:
25023489
10.

A novel signaling pathway regulates colon cancer angiogenesis through Norrin.

Planutis K, Planutiene M, Holcombe RF.

Sci Rep. 2014 Jul 9;4:5630. doi: 10.1038/srep05630.

11.

Cancer clinical research: return on investment in the era of value-based purchasing.

Holcombe RF.

J Oncol Pract. 2014 Sep;10(5):327-8. doi: 10.1200/JOP.2014.001416. Epub 2014 Jun 17. No abstract available.

12.

Implementation of electronic chemotherapy ordering: an opportunity to improve evidence-based oncology care.

Adelson KB, Qiu YC, Evangelista M, Spencer-Cisek P, Whipple C, Holcombe RF.

J Oncol Pract. 2014 Mar;10(2):e113-9. doi: 10.1200/JOP.2013.001184. Epub 2013 Dec 26.

13.

Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.

Pintova S, Sidhu H, Friedlander PA, Holcombe RF.

Melanoma Res. 2013 Dec;23(6):498-501. doi: 10.1097/CMR.0000000000000017.

PMID:
24113862
14.
15.

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.

Planutis K, Planutiene M, Nguyen AV, Moyer MP, Holcombe RF.

J Transl Med. 2013 Feb 26;11:50. doi: 10.1186/1479-5876-11-50.

16.

Clinical pathways for pancreatic neuroendocrine tumors.

Alistar A, Sung M, Kim M, Holcombe RF.

J Gastrointest Cancer. 2012 Dec;43(4):532-40. doi: 10.1007/s12029-012-9397-y. Review.

PMID:
22661335
17.

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Dellinger TH, Planutis K, Jandial DD, Eskander RN, Martinez ME, Zi X, Monk BJ, Holcombe RF.

Gynecol Oncol. 2012 Aug;126(2):259-67. doi: 10.1016/j.ygyno.2012.04.026. Epub 2012 Apr 30.

18.
20.

Role of canonical Wnt signaling in endometrial carcinogenesis.

Dellinger TH, Planutis K, Tewari KS, Holcombe RF.

Expert Rev Anticancer Ther. 2012 Jan;12(1):51-62. doi: 10.1586/era.11.194. Review.

PMID:
22149432
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk